| ESR1 | Ishikawa (endometrial adenocarcinoma) | 1 h with 10 nM Estradiol (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BIY | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | 1 h with 100 nM Genistein (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BJS | MA0112.3 | 
  
    
    | ESR1 | Ishikawa (endometrial adenocarcinoma) | 1 h with 100 nM Genistein (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BKL | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | 1 h with 10 nM Estradiol (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BKN | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | 1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BLL | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | 100nM bisphenol A (CHEBI:33216) for 30 minute | Permissive
      
      Robust | Homo sapiens | ENCSR000BQD | MA0112.3 | 
  
    
    | ESR1 | Ishikawa (endometrial adenocarcinoma) | 1 h with 100 nM Bisphenol A (Myers) | Permissive | Homo sapiens | ENCSR000BQR | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | hormone starved for 3 days, treated with 1% ethanol for 45 minutes | Permissive
      
      Robust | Homo sapiens | GSE19013
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | hormone starved for 3 days, treated with 10 nM β-estradiol for 45 minutes | Permissive
      
      Robust | Homo sapiens | GSE19013
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE26083
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Estrogen | Permissive
      
      Robust | Homo sapiens | GSE24166
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | ETOH (ethanol) | Permissive
      
      Robust | Homo sapiens | GSE23893
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE23893
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | ETOH (ethanol) | Permissive
      
      Robust | Homo sapiens | GSE23893
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | ETOH (ethanol) | Permissive
      
      Robust | Homo sapiens | GSE23893
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | Ishikawa (endometrial adenocarcinoma) | E2 | Permissive | Homo sapiens | GSE23893
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | Ishikawa (endometrial adenocarcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE23893
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | ECC-1 (endometrial adenocarcinoma) | ETOH (ethanol) | Permissive | Homo sapiens | GSE23893
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | ECC-1 (endometrial adenocarcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE23893
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | H3396 (breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE32332
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | H3396 (breast carcinoma) | E2 | Permissive | Homo sapiens | GSE32332
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | H3396 (breast carcinoma) | E2 | Permissive | Homo sapiens | GSE32332
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | H3396 (breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE32332
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | oestrogen | Permissive
      
      Robust | Homo sapiens | GSE25021
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | vehicle | Permissive
      
      Robust | Homo sapiens | GSE25021
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterus | vehicle | Permissive
      
      Robust | Mus musculus | GSE36455
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterus | estradiol | Permissive
      
      Robust | Mus musculus | GSE36455
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | mammary cells | untreated | Permissive | Mus musculus | GSE46123
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | mammary cells | Dexamethasone for 30 minutes | Permissive | Mus musculus | GSE46123
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | mammary cells | Estradiol for 30 minutes | Permissive
      
      Robust | Mus musculus | GSE46123
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | mammary cells | Dexamethasone + Estradiol for 30 minutes | Permissive
      
      Robust | Mus musculus | GSE46123
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | mammary cells | Estradiol for 30 minutes | Permissive
      
      Robust | Mus musculus | GSE46123
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | mammary cells | Dexamethasone + Estradiol for 30 minutes | Permissive
      
      Robust | Mus musculus | GSE46123
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | 7438 (mammary carcinoma) | untreated | Permissive
      
      Robust | Mus musculus | GSE46123
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | 7438 (mammary carcinoma) | Estradiol for 30 minutes | Permissive
      
      Robust | Mus musculus | GSE46123
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | 7438 (mammary carcinoma) | Dexamethasone + Estradiol for 30 minutes | Permissive
      
      Robust | Mus musculus | GSE46123
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | aortic cells | 10 nM beta-estradiol (E2) | Permissive | Mus musculus | GSE52351
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | liver | 10 nM beta-estradiol (E2) | Permissive
      
      Robust | Mus musculus | GSE52351
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | liver | 10 nM beta-estradiol (E2) | Permissive
      
      Robust | Mus musculus | GSE52351
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterine cells | saline vehicle | Permissive | Mus musculus | GSE56466
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | none | Permissive | Homo sapiens | GSE60517
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | none | Permissive | Homo sapiens | GSE60517
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | LTED (breast cancer) | none | Permissive
      
      Robust | Homo sapiens | GSE60517
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | LTED (breast cancer) | none | Permissive
      
      Robust | Homo sapiens | GSE60517
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 1hr with ethanol, crosslinked with 1% formaldehyde | Permissive
      
      Robust | Homo sapiens | GSE62222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 1hr with 100nM E2, crosslinked with 1% formaldehyde | Permissive
      
      Robust | Homo sapiens | GSE62222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | cells transfected with siNCAPG, and 1hr with 100nM E2, double crosslinked | Permissive
      
      Robust | Homo sapiens | GSE62222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | cells transfected with siNCAPD3 and H2 together, and 1hr with 100nM E2, double crosslinked | Permissive
      
      Robust | Homo sapiens | GSE62222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | cells transfected with siCTL, and 1hr with 100nM E2, double crosslinked | Permissive
      
      Robust | Homo sapiens | GSE62222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Vehicle | Permissive | Homo sapiens | GSE68357
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE68357
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2+PG | Permissive
      
      Robust | Homo sapiens | GSE68357
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | liver | Placebo | Permissive
      
      Robust | Mus musculus | GSE70346
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | liver | E2 | Permissive
      
      Robust | Mus musculus | GSE70346
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | liver | E2, ER KO | Permissive | Mus musculus | GSE70346
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | sgRNA_enh588 | Permissive
      
      Robust | Homo sapiens | GSE75779
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | sgRNA_enh588 | Permissive
      
      Robust | Homo sapiens | GSE75779
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100nM E2, 120min | Permissive
      
      Robust | Homo sapiens | GSE76893
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Vehicle treatment | Permissive
      
      Robust | Homo sapiens | GSE78284
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 treatment | Permissive
      
      Robust | Homo sapiens | GSE78284
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Vehicle treatment | Permissive
      
      Robust | Homo sapiens | GSE78284
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 treatment | Permissive
      
      Robust | Homo sapiens | GSE78284
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | Vehicle | Permissive | Homo sapiens | GSE80367
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | 10 nM Estradiol | Permissive | Homo sapiens | GSE80367
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | 10 nM R5020 | Permissive | Homo sapiens | GSE80367
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | 10nM Estradiol + 10 nM R5020 | Permissive
      
      Robust | Homo sapiens | GSE80367
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | Vehicle | Permissive | Homo sapiens | GSE80367
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | 10 nM Estradiol | Permissive
      
      Robust | Homo sapiens | GSE80367
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | 10 nM R5020 | Permissive | Homo sapiens | GSE80367
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | 10nM Estradiol + 10 nM R5020 | Permissive | Homo sapiens | GSE80367
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | DMSO | Permissive
      
      Robust | Homo sapiens | GSE80728
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE80728
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | DMSO | Permissive
      
      Robust | Homo sapiens | GSE80728
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE80728
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | tumor A | Permissive
      
      Robust | Homo sapiens | GSE81213
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | tumor C | Permissive
      
      Robust | Homo sapiens | GSE81213
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | tumor D | Permissive | Homo sapiens | GSE81213
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | tumor E | Permissive
      
      Robust | Homo sapiens | GSE81213
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | tumor B | Permissive
      
      Robust | Homo sapiens | GSE81213
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterus | IGF1 | Permissive
      
      Robust | Mus musculus | GSE100023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterus | ICI 182,780 | Permissive
      
      Robust | Mus musculus | GSE100023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | U2OS (osteosarcoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE26110
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | IKK7 | Permissive | Homo sapiens | GSE67295
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | IL1b+IKK7 | Permissive | Homo sapiens | GSE67295
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2+ICI | Permissive
      
      Robust | Homo sapiens | GSE67295
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | IL1b+ICI | Permissive
      
      Robust | Homo sapiens | GSE67295
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 for 45m | Permissive
      
      Robust | Homo sapiens | GSE67295
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | IL1b for 45m | Permissive
      
      Robust | Homo sapiens | GSE67295
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | TNFa for 45m | Permissive
      
      Robust | Homo sapiens | GSE67295
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | ICI | Permissive
      
      Robust | Homo sapiens | GSE81510
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE81510
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2, DEX | Permissive
      
      Robust | Homo sapiens | GSE81510
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | DMSO | Permissive
      
      Robust | Homo sapiens | GSE84593
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | BYL719 | Permissive
      
      Robust | Homo sapiens | GSE84593
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | control; 100 nM 17-beta-estradiol for 0h | Permissive | Homo sapiens | GSE85106
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100 nM 17-beta-estradiol for 45 min | Permissive | Homo sapiens | GSE85106
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100 nM 17-beta-estradiol for 3h | Permissive | Homo sapiens | GSE85106
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | siCTCF | Permissive
      
      Robust | Homo sapiens | GSE85106
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | siNT | Permissive
      
      Robust | Homo sapiens | GSE85106
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | White Medium + E2 | Permissive
      
      Robust | Homo sapiens | GSE86538
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) | White Medium | Permissive
      
      Robust | Homo sapiens | GSE86538
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | White Medium | Permissive
      
      Robust | Homo sapiens | GSE86538
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | White Medium + E2 | Permissive
      
      Robust | Homo sapiens | GSE86538
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | breast tumor xenograft | estrogen | Permissive
      
      Robust | Homo sapiens | GSE93108
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | breast tumor xenograft | estrogen plus progesterone | Permissive
      
      Robust | Homo sapiens | GSE93108
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | NoTreat | Permissive
      
      Robust | Homo sapiens | GSE94023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 5min E2 | Permissive
      
      Robust | Homo sapiens | GSE94023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 10min E2 | Permissive
      
      Robust | Homo sapiens | GSE94023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 20min E2 | Permissive
      
      Robust | Homo sapiens | GSE94023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 40min E2 | Permissive
      
      Robust | Homo sapiens | GSE94023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 80min E2 | Permissive
      
      Robust | Homo sapiens | GSE94023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 160min E2 | Permissive
      
      Robust | Homo sapiens | GSE94023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 320min E2 | Permissive
      
      Robust | Homo sapiens | GSE94023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 640min E2 | Permissive
      
      Robust | Homo sapiens | GSE94023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 1280min E2 | Permissive
      
      Robust | Homo sapiens | GSE94023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | Tamoxifen-associated | Permissive
      
      Robust | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | Tamoxifen-associated | Permissive | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | Tamoxifen-associated | Permissive | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | Tamoxifen-associated | Permissive | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | Tamoxifen-associated | Permissive
      
      Robust | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma | Tamoxifen-associated | Permissive | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Doxycycline | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Doxycycline + E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Doxycycline | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Doxycycline | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Doxycycline + E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Doxycycline + E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Doxycycline | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Doxycycline + E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | Doxycycline | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | Doxycycline + E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | none | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | none | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Doxycycline | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Doxycycline + E2 | Permissive
      
      Robust | Homo sapiens | GSE94493
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterus | 250 ng of estradiol (E2); mutant ERa | Permissive | Mus musculus | GSE94737
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) | vehicle | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | siNT | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | siFOXA1 | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Cocktail_90 | Permissive
      
      Robust | Homo sapiens | GSE32222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) | Tam-Resist | Permissive
      
      Robust | Homo sapiens | GSE32222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | BT-474 (breast invasive ductal carcinoma) | Tam-Resist | Permissive
      
      Robust | Homo sapiens | GSE32222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | ZR-75-1 (invasive ductal carcinoma) | Tam-Responsive | Permissive
      
      Robust | Homo sapiens | GSE32222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Tam-Responsive | Permissive
      
      Robust | Homo sapiens | GSE32222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | breast tumor | ER- | Permissive | Homo sapiens | GSE32222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | breast tumour metastasis | Metastasis | Permissive
      
      Robust | Homo sapiens | GSE32222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | breast tumor | Non-responder | Permissive | Homo sapiens | GSE32222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | breast tumor | Responder | Permissive
      
      Robust | Homo sapiens | GSE32222
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF10A (breast epithelial cells) | Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with 100nM 4-OHT for 24h. | Permissive
      
      Robust | Homo sapiens | GSE59146
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF10A (breast epithelial cells) | Cells were lentivirally transduced with MYC-ERVD and stable pools were treated with solvent control for 24h. | Permissive | Homo sapiens | GSE59146
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF10A (breast epithelial cells) | Cells were lentivirally transduced with MYC-ER and stable pools were treated with solvent control for 24h. | Permissive | Homo sapiens | GSE59146
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | breast tumor | Female | Permissive
      
      Robust | Homo sapiens | GSE104399
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | breast tumor | Male | Permissive
      
      Robust | Homo sapiens | GSE104399
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100 nM ICI for 30 min | Permissive
      
      Robust | Homo sapiens | GSE108883
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 5 nM E2 for 30 min | Permissive
      
      Robust | Homo sapiens | GSE108883
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | vehicle for 3h | Permissive
      
      Robust | Homo sapiens | GSE108883
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | ICI for 3h | Permissive
      
      Robust | Homo sapiens | GSE108883
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 for 3h | Permissive
      
      Robust | Homo sapiens | GSE108883
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | control | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100nm E2 (45 min) | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100nm E2 (90 min) | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | control | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100nm E2 (45 min) | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100nm E2 (90 min) | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | control | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100nm E2 (45 min) | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100nm E2 (90 min) | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | control | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100nm E2 (45 min) | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 100nm E2 (90 min) | Permissive
      
      Robust | Homo sapiens | GSE109820
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: ethanol 1hr; | Permissive
      
      Robust | Homo sapiens | GSE102410
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: 17beta estradiol 10nM for 1hr; | Permissive
      
      Robust | Homo sapiens | GSE102410
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: tamoxifen 1μM for 1hr; | Permissive
      
      Robust | Homo sapiens | GSE102410
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: vehicle(DMSO 2 hr); Passage: p19; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 500nM RAD001 2hr; Passage: p19; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 500 nM AZD201 2 hr; Passage: p19; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: vehicle(DMSO 2 hr); Passage: p20; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 500nM RAD001 2hr; Passage: p20; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 500 nM AZD201 2 hr; Passage: p20; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: vehicle(DMSO 2 hr); Passage: p21; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 500nM RAD001 2hr; Passage: p21; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 500 nM AZD201 2 hr; Passage: p21; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: vehicle(DMSO 2 hr); Passage: p22; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 500nM RAD001 2hr; Passage: p22; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 500 nM AZD201 2 hr; Passage: p22; | Permissive
      
      Robust | Homo sapiens | GSE103023
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells | Permissive | Homo sapiens | GSE107176
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MDA-MB-134 (invasive lobular breast carcinoma) | Treatment: DMSO Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line | Permissive
      
      Robust | Homo sapiens | GSE109103
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MDA-MB-134 (invasive lobular breast carcinoma) | Treatment: 100 nM estradiol (E2) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line | Permissive
      
      Robust | Homo sapiens | GSE109103
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MDA-MB-134 (invasive lobular breast carcinoma) | Treatment: a cocktail of 10 µM forskolin plus 100 µM 3-isobutyl-1-methylxanthine (FI) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line | Permissive
      
      Robust | Homo sapiens | GSE109103
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | Ishikawa (endometrial adenocarcinoma) | Treatment: 100 nM Dexamethasone and 10 nM Estradiol for 1 hour | Permissive
      
      Robust | Homo sapiens | GSE109891
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | Ishikawa (endometrial adenocarcinoma) | Treatment: 10 nM Estradiol for 1 hour | Permissive
      
      Robust | Homo sapiens | GSE109891
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | Ishikawa (endometrial adenocarcinoma) | Treatment: DMSO (vehicle) for 1 hour | Permissive | Homo sapiens | GSE109891
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | DMSO | Permissive | Homo sapiens | GSE115607
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | H3B-6545 | Permissive
      
      Robust | Homo sapiens | GSE115607
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Saturated H3B-6545 | Permissive
      
      Robust | Homo sapiens | GSE115607
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 800 | Permissive
      
      Robust | Homo sapiens | GSE115607
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Rad1901 | Permissive
      
      Robust | Homo sapiens | GSE115607
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | H3B-5942 | Permissive
      
      Robust | Homo sapiens | GSE115607
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Saturated H3B-5942 | Permissive
      
      Robust | Homo sapiens | GSE115607
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Tamoxifen | Permissive
      
      Robust | Homo sapiens | GSE115607
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Fulvestrant | Permissive
      
      Robust | Homo sapiens | GSE115607
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE115607
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days | Permissive
      
      Robust | Homo sapiens | GSE116170
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | CellSubtype:Stable ESR1-YAP1 fusion expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days | Permissive | Homo sapiens | GSE116170
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | CellSubtype: stable ESR1-PCDH11X fusion expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days | Permissive
      
      Robust | Homo sapiens | GSE116170
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | CellSubtype: stable ESR1-NOP2 fusion expressing model Treatment: hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days | Permissive | Homo sapiens | GSE116170
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | CellSubtype: stable YFP-HA expressing model Treatment: Hormone-deprived media using RPMI1640 without phenol red and 10% charcoal-stripped FBS) for 5-7 days | Permissive | Homo sapiens | GSE116170
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: DMSO for 45 min  Genotype: wildtype TET2 Passage: 6-10 | Permissive
      
      Robust | Homo sapiens | GSE120756
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: E2 (estrogen) for 45 min  Genotype: wildtype TET2 Passage: 6-10 | Permissive
      
      Robust | Homo sapiens | GSE120756
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: DMSO for 45 min  Genotype: TET2 knockout Passage: 6-10 | Permissive
      
      Robust | Homo sapiens | GSE120756
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: E2 (estrogen) for 45 min  Genotype: TET2 knockout Passage: 6-10 | Permissive
      
      Robust | Homo sapiens | GSE120756
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: DMSO for 45 min  Genotype: wildtype TET2 Passage: 6-10 | Permissive | Homo sapiens | GSE120756
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: E2 (estrogen) for 45 min  Genotype: wildtype TET2 Passage: 6-10 | Permissive
      
      Robust | Homo sapiens | GSE120756
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MDA-MB-231 (breast adenocarcinoma) | treatment: E2, 100 nM, 0 min Genotype: ER-alfa wildtype | Permissive | Homo sapiens | GSE95121
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MDA-MB-231 (breast adenocarcinoma) | Treatment: E2, 100 nM, 45 min Genotype: ER-alfa wildtype | Permissive
      
      Robust | Homo sapiens | GSE95121
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MDA-MB-231 (breast adenocarcinoma) | Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q | Permissive | Homo sapiens | GSE95121
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MDA-MB-231 (breast adenocarcinoma) | Treatment: E2, 100 nM, 0 min Genotype: ER-alfa L540Q | Permissive
      
      Robust | Homo sapiens | GSE95121
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | Passsage: <10 | Permissive
      
      Robust | Homo sapiens | GSE99479
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | Passsage: <10 | Permissive
      
      Robust | Homo sapiens | GSE99479
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | Passsage: <10 Genotype: wt/R330fs mutant with CRISPR | Permissive
      
      Robust | Homo sapiens | GSE99479
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | Passsage: <10 Genotype: wt/R330fs mutant with CRISPR | Permissive
      
      Robust | Homo sapiens | GSE99479
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10nM Estradiol + 10 nM DHT for 45 mins Genotype: ER+/PR+ | Permissive | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: Vehicle for 60 mins Genotype: ER+/PR+ | Permissive
      
      Robust | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 15 mins of 10nM Estradiol and then 10nM Estradiol + 10 nM Dexamethasone for 60 mins Genotype: ER+/PR+ | Permissive
      
      Robust | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10 nM Aldosterone for 45 mins Genotype: ER+/PR+ | Permissive | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10nM Estradiol + 10 nM Aldosterone for 45 mins Genotype: ER+/PR+ | Permissive
      
      Robust | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | 10nM Estradiol + 10 nM Dexamethasone | Permissive | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: Vehicle for4 hrs Genotype: ER+/PR+ | Permissive
      
      Robust | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10 nM E2 for4 hrs Genotype: ER+/PR+ | Permissive
      
      Robust | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10 nM R5020 for45 mins Genotype: ER+/PR+ | Permissive
      
      Robust | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10 nM E2 + 10 nM R5020 for45 mins Genotype: ER+/PR+ | Permissive
      
      Robust | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatmet: Vehicle, 45 min Genotype: ER+/PR+ | Permissive | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10 nM Estradiol for 45 mins Genotype: ER+/PR+ | Permissive
      
      Robust | Homo sapiens | GSE99626
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: FA (control) | Permissive
      
      Robust | Homo sapiens | GSE114737
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment:  2 mM DSG for 25 mins | Permissive
      
      Robust | Homo sapiens | GSE114737
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | primary breast cancer | Treatment:  2 mM DSG for 25 mins | Permissive
      
      Robust | Homo sapiens | GSE114737
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | primary endometrium cancer | Treatment: FA (control) | Permissive
      
      Robust | Homo sapiens | GSE114737
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | primary endometrium cancer | Treatment:  2 mM DSG for 25 mins | Permissive
      
      Robust | Homo sapiens | GSE114737
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER | Permissive | Homo sapiens | GSE117569
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER | Permissive | Homo sapiens | GSE117569
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER | Permissive
      
      Robust | Homo sapiens | GSE117569
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER | Permissive
      
      Robust | Homo sapiens | GSE117569
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: pS118-ER | Permissive
      
      Robust | Homo sapiens | GSE117569
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: pS118-ER | Permissive | Homo sapiens | GSE117569
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 10 nM 17-beta-estradiol for 30 mins Genotype: wildtype ER | Permissive
      
      Robust | Homo sapiens | GSE117569
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: vehicle (0.01% EtOH) for 30 mins Genotype: wildtype-ER | Permissive
      
      Robust | Homo sapiens | GSE117569
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | B-cells | Genotype: wildtype; Strain: C57BL/6; Tissue: spleen; | Permissive | Mus musculus | GSE66424
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7L-P(immortalized breast epithelial cell line) | Treatment: untreated; | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7L-P(immortalized breast epithelial cell line) | Treatment: treated with E2 for 1 hr; | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7L-P(immortalized breast epithelial cell line) | Treatment: treated with E2 for 4 hrs; | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7L-P(immortalized breast epithelial cell line) | Treatment: treated with E2 for 16 hrs; | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7L-P(immortalized breast epithelial cell line) | Treatment: treated with E2 for 24 hrs; | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: with Estrogen; | Permissive
      
      Robust | Homo sapiens | GSE117492
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | Treatment: with Estrogen +1,6-Hexanediol; | Permissive
      
      Robust | Homo sapiens | GSE117492
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | sperm | Strain: CD1; | Permissive | Mus musculus | GSE116855
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterus | Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 6 hrs; Strain: C57BL/6J; | Permissive
      
      Robust | Mus musculus | GSE125972
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterus | Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 8 hrs; Strain: C57BL/6J; | Permissive
      
      Robust | Mus musculus | GSE125972
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterus | Age: adult; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline for 12 hrs; Strain: C57BL/6J; | Permissive
      
      Robust | Mus musculus | GSE125972
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterus | Age: 21 day; Treatment: 250 ng E2 dissolved in 0.1 ml of normal saline; Strain: C57BL/6J; | Permissive | Mus musculus | GSE125972
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | E2_TAM | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0112.3 | 
  
    
    | ESR1 | ZR-75-1 (invasive ductal carcinoma) | E2_TAM | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | ERP000901 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | LY2 | Permissive
      
      Robust | Homo sapiens | ERP003844 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE14664 | MA0112.3 | 
  
    
    | ESR1 | HCC-1428 (breast adenocarcinoma) | TLED | Permissive | Homo sapiens | GSE27300 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | TLED | Permissive
      
      Robust | Homo sapiens | GSE27300 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SHESR1 | Permissive
      
      Robust | Homo sapiens | GSE53531 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2_JQ1 | Permissive
      
      Robust | Homo sapiens | GSE55921 | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE68356 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive | Homo sapiens | GSE26083
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive | Homo sapiens | GSE33804
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive | Homo sapiens | GSE24166
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | liver |  | Permissive
      
      Robust | Mus musculus | GSE49993
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | uterus |  | Permissive
      
      Robust | Mus musculus | GSE49993
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | mammary gland |  | Permissive
      
      Robust | Mus musculus | GSE43415
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE49390
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE49390
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF10A (breast epithelial cells) |  | Permissive
      
      Robust | Homo sapiens | GSE59001
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | preantral follicles |  | Permissive
      
      Robust | Mus musculus | GSE62545
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive | Homo sapiens | GSE73320
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE74033
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE75779
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE75779
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | mammary gland |  | Permissive | Mus musculus | GSE77586
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive | Homo sapiens | GSE67295
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | patient-derived pleaural effusion | N/A | Permissive
      
      Robust | Homo sapiens | GSE86538
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma |  | Permissive | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma |  | Permissive
      
      Robust | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma |  | Permissive | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma |  | Permissive | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma |  | Permissive | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | endometrioid adenocarcinoma |  | Permissive | Homo sapiens | GSE94031
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE116768
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7L-TamR(immortalized breast epithelial, tamoxifen resistant cell line) |  | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ERP000783 | MA0112.3 | 
  
    
    | ESR1 | ZR-75-1 (invasive ductal carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ERP000783 | MA0112.3 | 
  
    
    | ESR1 |  |  | Permissive
      
      Robust | Homo sapiens | ERP003828 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive | Homo sapiens | GSE35109 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE41561 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE45822 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE48930 | MA0112.3 | 
  
    
    | ESR1 |  |  | Permissive
      
      Robust | Homo sapiens | GSE68356 | MA0112.3 | 
  
    
    | ESR1 |  |  | Permissive | Homo sapiens | GSE68356 | MA0112.3 | 
  
    
    | ESR1 |  |  | Permissive
      
      Robust | Homo sapiens | GSE68356 | MA0112.3 | 
  
    
    | ESR1 |  |  | Permissive | Homo sapiens | GSE68356 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | ERP000209 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2_TAM | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SHCRT_E2 | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SHFOXA1_E2 | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | TAM | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | TAMR | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | TAMR_TAM | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0112.3 | 
  
    
    | ESR1 |  | glyc | Permissive
      
      Robust | Homo sapiens | ERP002305 | MA0112.3 | 
  
    
    | ESR1 |  | mrnahist | Permissive | Homo sapiens | ERP002305 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | GLYC | Permissive
      
      Robust | Homo sapiens | ERP002305 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | MRNAHIST | Permissive
      
      Robust | Homo sapiens | ERP002305 | MA0112.3 | 
  
    
    | ESR1 | H3396 (breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE32349 | MA0112.3 | 
  
    
    | ESR1 | H3396 (breast carcinoma) | ETOH | Permissive
      
      Robust | Homo sapiens | GSE32349 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SICTR_E2 | Permissive
      
      Robust | Homo sapiens | GSE40129 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SIGATA_E2 | Permissive
      
      Robust | Homo sapiens | GSE40129 | MA0112.3 | 
  
    
    | ESR1 | ZR-75-1 (invasive ductal carcinoma) | SICTR_E2 | Permissive
      
      Robust | Homo sapiens | GSE40129 | MA0112.3 | 
  
    
    | ESR1 | ZR-75-1 (invasive ductal carcinoma) | SIGATA_E2 | Permissive
      
      Robust | Homo sapiens | GSE40129 | MA0112.3 | 
  
    
    | ESR1 |  | tumor_BADOUTCOME | Permissive | Homo sapiens | GSE40867 | MA0112.3 | 
  
    
    | ESR1 |  | tumor_GOODOUTCOME | Permissive
      
      Robust | Homo sapiens | GSE40867 | MA0112.3 | 
  
    
    | ESR1 | VCaP (prostate carcinoma) | E2 | Permissive | Homo sapiens | GSE43985 | MA0112.3 | 
  
    
    | ESR1 | VCaP (prostate carcinoma) | E2_ERA | Permissive
      
      Robust | Homo sapiens | GSE43985 | MA0112.3 | 
  
    
    | ESR1 | MDA-MB-134 (invasive lobular breast carcinoma) | ESTROGEN | Permissive | Homo sapiens | GSE51022 | MA0112.3 | 
  
    
    | ESR1 | MDA-MB-134 (invasive lobular breast carcinoma) | ETOH | Permissive
      
      Robust | Homo sapiens | GSE51022 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | LETR | Permissive
      
      Robust | Homo sapiens | GSE54592 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | LETR_ANDRO | Permissive
      
      Robust | Homo sapiens | GSE54592 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | LY2_ETOH | Permissive
      
      Robust | Homo sapiens | GSE54592 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2_10M | Permissive
      
      Robust | Homo sapiens | GSE54855 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2_120M | Permissive
      
      Robust | Homo sapiens | GSE54855 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2_2M | Permissive
      
      Robust | Homo sapiens | GSE54855 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2_40M | Permissive
      
      Robust | Homo sapiens | GSE54855 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2_5M | Permissive
      
      Robust | Homo sapiens | GSE54855 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE59530 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2_TNF | Permissive
      
      Robust | Homo sapiens | GSE59530 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SHCTR_E2_TNF | Permissive
      
      Robust | Homo sapiens | GSE59530 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SHFOXA1_E2_TNF | Permissive
      
      Robust | Homo sapiens | GSE59530 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | TNF | Permissive
      
      Robust | Homo sapiens | GSE59530 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE60270 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SHCTR | Permissive
      
      Robust | Homo sapiens | GSE60270 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SHCTR_E2 | Permissive
      
      Robust | Homo sapiens | GSE60270 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SHFOXA1_E2 | Permissive
      
      Robust | Homo sapiens | GSE60270 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | SHGATA3_E2 | Permissive
      
      Robust | Homo sapiens | GSE60270 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | PROG | Permissive
      
      Robust | Homo sapiens | GSE68355 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | R5020 | Permissive
      
      Robust | Homo sapiens | GSE68355 | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | PROG | Permissive
      
      Robust | Homo sapiens | GSE68355 | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | R5020 | Permissive
      
      Robust | Homo sapiens | GSE68355 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE68356 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2PG | Permissive
      
      Robust | Homo sapiens | GSE68356 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE71276 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE72249 | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE72249 | MA0112.3 | 
  
    
    | ESR1 | ZR-75-1 (invasive ductal carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE72249 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ERP000209 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive | Homo sapiens | GSE54855 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE59530 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE60270 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE68355 | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE68355 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive | Homo sapiens | GSE68356 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive | Homo sapiens | GSE71276 | MA0112.3 | 
  
    
    | ESR1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE72249 | MA0112.3 | 
  
    
    | ESR1 | T47D (invasive ductal carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE72249 | MA0112.3 | 
  
    
    | ESR1 | ZR-75-1 (invasive ductal carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE72249 | MA0112.3 |